{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:11:20Z","timestamp":1784837480109,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["ANR-11-INBS-0006"],"award-info":[{"award-number":["ANR-11-INBS-0006"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bulcan.2026.02.013","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:14:54Z","timestamp":1778188494000},"page":"953-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00ab\u00a0Tumour targeting, Imaging, RadiotherapieS\u00a0\u00bb\u00a0\u2013\u00a0XVIIe \u00e9dition de l\u2019atelier organis\u00e9 par le r\u00e9seau \u00ab\u00a0Vectorisation, Imagerie, Radioth\u00e9rapies\u00a0\u00bb du Canc\u00e9rop\u00f4le Grand-Ouest, 9\u201312\u00a0octobre 2024, Erquy, France"],"prefix":"10.1016","volume":"113","author":[{"given":"Fran\u00e7oise","family":"L\u00e9ost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ch\u00e9rel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Rbah-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Troadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.02.013_bib0120","doi-asserted-by":"crossref","first-page":"1034315","DOI":"10.3389\/fmed.2022.1034315","article-title":"Alpha-peptide receptor radionuclide therapy using actinium-225\u00a0labeled somatostatin receptor agonists and antagonists","volume":"9","author":"Shi","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.bulcan.2026.02.013_bib0125","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S1470-2045(24)00030-5","article-title":"Recent advances and impending challenges for the radiopharmaceutical sciences in oncology","volume":"25","author":"Lapi","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2026.02.013_bib0130","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.2147\/IJN.S336299","article-title":"Targeted PET\/MRI imaging super probes: a critical review of opportunities and challenges","volume":"16","author":"Kastelik-Hryniewiecka","year":"2022","journal-title":"Int J Nanomed"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.013_bib0135","doi-asserted-by":"crossref","first-page":"e220157","DOI":"10.1148\/rycan.220157","article-title":"A review of theranostics: perspectives on emerging approaches and clinical advancements","volume":"5","author":"Burkett","year":"2023","journal-title":"Radiol Imaging Cancer"},{"issue":"37","key":"10.1016\/j.bulcan.2026.02.013_bib0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411583121","article-title":"Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer","volume":"121","author":"Armanetti","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.013_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/biom14040491","article-title":"Radiolabelled FGF-2\u00a0for imaging activated fibroblasts in the tumor micro-environment","volume":"14","author":"Bentivoglio","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.bulcan.2026.02.013_bib0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1039\/D2CC06602E","article-title":"Highly inert Cu(II) complexes of C-aryl bifunctional cyclam-picolinates with remarkable 64Cu-labelling and biodistribution","volume":"59","author":"Pineau","year":"2023","journal-title":"Chem Commun (Camb)"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.013_bib0155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.7150\/thno.92775","article-title":"Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside","volume":"14","author":"Van Laere","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bulcan.2026.02.013_bib0160","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2967\/jnumed.123.265524","article-title":"Albumin-binding and conventional PSMA ligands in combination with 161Tb: Biodistribution, dosimetry, and preclinical therapy","volume":"64","author":"Tschan","year":"2023","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.bulcan.2026.02.013_bib0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10439-025-03712-3","article-title":"Multifunctional magnetic nanoparticles for targeted drug delivery against cancer: a review of mechanisms, applications, consequences, limitations, and tailoring strategies","volume":"53","author":"Riaz","year":"2025","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.013_bib0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acs.bioconjchem.5c00102","article-title":"E. coli\u00a0as a smart thermo-vector for combating solid tumors: a synergistic heat-induced cancer therapy approach","volume":"36","author":"Kaur","year":"2025","journal-title":"Bioconjug Chem"},{"issue":"8","key":"10.1016\/j.bulcan.2026.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3390\/molecules29081824","article-title":"Influence of SPION surface coating on magnetic properties and theranostic profile","volume":"29","author":"Ferreira-Filho","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.013_bib0180","doi-asserted-by":"crossref","first-page":"e009548","DOI":"10.1136\/jitc-2024-009548","article-title":"Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy","volume":"13","author":"Desroys du Roure","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.013_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40425-019-0498-z","article-title":"Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies","volume":"7","author":"Ashraf","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2026.02.013_bib0190","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bph.16291","article-title":"Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer","volume":"183","author":"David","year":"2026","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.013_bib0195","doi-asserted-by":"crossref","first-page":"e007135","DOI":"10.1136\/jitc-2023-007135","article-title":"A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer","volume":"12","author":"Desroys du Roure","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bulcan.2026.02.013_bib0200","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm Res"},{"issue":"16","key":"10.1016\/j.bulcan.2026.02.013_bib0205","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1039\/D3NR05082C","article-title":"Self-propelling bacteria-based magnetic nanoparticles (BacMags) for targeted magnetic hyperthermia therapy against hypoxic tumors","volume":"16","author":"Kaur","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.bulcan.2026.02.013_bib0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/adma.200701726","article-title":"Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery","volume":"20","author":"Kim","year":"2008","journal-title":"Adv Mater"},{"key":"10.1016\/j.bulcan.2026.02.013_bib0215","doi-asserted-by":"crossref","first-page":"015078","DOI":"10.1088\/2053-1591\/ab6700","article-title":"PEGlatyon-SPION surface functionalization with folic acid for magnetic hyperthermia applications","volume":"7","author":"Piazza","year":"2020","journal-title":"Mater Res Express"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.013_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12645-017-0029-x","article-title":"Particle therapy and nanomedicine: state of art and research perspectives","volume":"8","author":"Lacombe","year":"2017","journal-title":"Cancer Nanotechnol"},{"issue":"7","key":"10.1016\/j.bulcan.2026.02.013_bib0225","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/pharmaceutics15071817","article-title":"Preclinical evaluation of a 64Cu-based theranostic approach in a murine model of multiple myeloma","volume":"15","author":"M\u00e9tivier","year":"2023","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.bulcan.2026.02.013_bib0230","doi-asserted-by":"crossref","first-page":"2001675","DOI":"10.1002\/advs.202001675","article-title":"Radiation dose-enhancement is a potent radiotherapeutic effect of rare-earth composite nanoscintillators in preclinical models of glioblastoma","volume":"7","author":"Bulin","year":"2020","journal-title":"Adv Sci (Weinh)"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:38:52Z","timestamp":1784835532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126001815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0007455126001815"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.02.013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00ab\u00a0Tumour targeting, Imaging, RadiotherapieS\u00a0\u00bb\u00a0\u2013\u00a0XVIIe \u00e9dition de l\u2019atelier organis\u00e9 par le r\u00e9seau \u00ab\u00a0Vectorisation, Imagerie, Radioth\u00e9rapies\u00a0\u00bb du Canc\u00e9rop\u00f4le Grand-Ouest, 9\u201312\u00a0octobre 2024, Erquy, France","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}